High plasma dimethylarginine levels are associated with adverse clinical outcome after stroke

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 9, 2011, Pages 753-761

  Worthmann, Hans ^a   Chen, Shufen ^a,b   Martens Lobenhoffer, Jens ^c   Li, Na ^a,d   Deb, Milani ^a   Tryc, Anita Blanka ^a   Goldbecker, Annemarie ^a   Dong, Qiang ^b   Kielstein, Jan Thomas ^a   Bode Böger, Stefanie Margarethe ^c   Weissenborn, Karin ^a,d  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^d CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

Asymmetric dimethylarginine (ADMA); L arginine; Outcome; Stroke; Symmetric dimethylarginine (SDMA)

Indexed keywords

6 N,N' DIMETHYLARGININE; ARGININE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LOGISTIC REGRESSION ANALYSIS; MALE; MASS SPECTROMETRY; NORMAL HUMAN; RANKIN SCALE; STROKE;

AGED; ARGININE; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; STROKE; TANDEM MASS SPECTROMETRY;

EID: 80053214199     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.8144     Document Type: Article

References (34)

1. Nishiyama Y, Ueda M, Katsura KI, Otsuka T, Abe A, Nagayama H, Katayama Y: Asymmetric dimethylarginine (adma) as a possible risk marker for ischemic stroke. J Neurol Sci, 2010; 290: 12-15
2. Kielstein JT, Bode-Boger SM, Frolich JC, Ritz E, Haller H, Fliser D: Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation, 2003; 107: 1891-1895
3. Vladimirova-Kitova L, Terzieva D, Marinov B: Intimamedia thickness and flow-mediated vasodilation in asymptomatic subjects with newly detected severe hypercholesterolemia. Echocardiography, 2009; 26: 1060-1068
4. Boger RH, Lentz SR, Bode-Boger SM, Knapp HR, Haynes WG: Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans. Clin Sci (Lond), 2001; 100: 161-167
5. Abbasi F, Asagmi T, Cooke JP, Lamendola C, McLaughlin T, Reaven GM, Stuehlinger M, Tsao PS: Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol, 2001; 88: 1201-1203
6. Kielstein JT, Zoccali C: Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? Am J Kidney Dis, 2005; 46: 186-202
7. Wanby P, Teerlink T, Brudin L, Brattstrom L, Nilsson I, Palmqvist P, Carlsson M: Asymmetric dimethylarginine (adma) as a risk marker for stroke and tia in a swedish population. Atherosclerosis, 2006; 185: 271-277
8. Yoo JH, Lee SC: Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis, 2001; 158: 425-430
9. Sydow K, Munzel T: Adma and oxidative stress. Atheroscler Suppl, 2003; 4: 41-51
10. Kondo T, Hirose M, Kageyama K: Roles of oxidative stress and redox regulation in atherosclerosis. J Atheroscler Thromb, 2009; 16: 532-538. Epub 2009 Sep 14. Review
11. Hirose H, Kawabe H, Komiya N, Saito I: Relations between serum reactive oxygen metabolites (ROMs) and various inflammatory and metabolic parameters in a Japanese population. J Atheroscler Thromb, 2009; 16: 77-82
12. Nishiyama Y, Ueda M, Otsuka T, Katsura KI, Abe A, Nagayama H, Katayama Y: Statin Treatment Decreased Serum Asymmetric Dimethylarginine (ADMA) Levels in Ischemic Stroke Patients. J Atheroscler Thromb, 2010; Nov 11. [Epub ahead of print]
13. Kirmizis D, Papagianni A, Dogrammatzi F, Skoura L, Belechri AM, Alexopoulos E, Efstratiadis G, Memmos D: Effects of simvastatin on markers of inflammation, oxidative stress and endothelial cell apoptosis in patients on chronic hemodialysis. J Atheroscler Thromb, 2010; 17: 1256-1265. Epub 2010 Sep 25
14. Meinitzer A, Kielstein JT, Pilz S, Drechsler C, Ritz E, Boehm BO, Winkelmann BR, März W: Symmetrical and Asymmetrical Dimethylarginine as Predictors for Mortality in Patients Referred for Coronary Angiography: The Ludwigshafen Risk and Cardiovascular Health Study. Clin Chem, 2010
15. Schulze F, Carter AM, Schwedhelm E, Ajjan R, Maas R, von Holten RA, Atzler D, Grant PJ, Boger RH: Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke. Atherosclerosis, 2010; 208: 518-523
16. Brouns R, Marescau B, Possemiers I, Sheorajpanday R, De Deyn PP: Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity. Neurochem Res, 2009; 34: 1642-1649
17. McColl BW, Allan SM, Rothwell NJ: Systemic infection, inflammation and acute ischemic stroke. Neuroscience, 2009; 158: 1049-1061
18. The national institute of neurological disorders and stroke rt-pa stroke study group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med, 1995; 333: 1581-1587
19. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment. Stroke, 1993; 24: 35-41
20. Martens-Lobenhoffer J, Bode-Boger SM: Fast and efficient determination of arginine, symmetric dimethylarginine, and asymmetric dimethylarginine in biological fluids by hydrophilic-interaction liquid chromatographyelectrospray tandem mass spectrometry. Clin Chem, 2006; 52: 488-493
21. Cooke JP: Asymmetrical Dimethylarginine The Über Marker? Circulation, 2004, 109: 1813-1819
22. Jin JS, D'Alecy LG: Central and peripheral effects of asymmetric dimethylarginine, an endogenous nitric oxide synthetase inhibitor. J Cardiovasc Pharmacol, 1996; 28: 439-446
23. Faraci FM, Brian JE Jr, Heistad DD: Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase. Am J Physiol, 1995; 269: H1522-H1527
24. Kielstein JT, Donnerstag F, Gasper S, Menne J, Kielstein A, Martens-Lobenhoffer J, Scalera F, Cooke JP, Fliser D, Bode-Boger SM: Adma increases arterial stiffness and decreases cerebral blood flow in humans. Stroke, 2006; 37: 2024-2029
25. Jung CS, Iuliano BA, Harvey-White J, Espey MG, Oldfield EH, Pluta RM: Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg, 2004; 101: 836-884
26. Kielstein JT, Veldink H, Martens-Lobenhoffer J, Haller H, Burg M, Lorenzen JM, Lichtinghagen R, Bode-Böger SM, Kliem V: SDMA is an early marker of change in GFR after living-related kidney donation. Nephrol Dial Transplant, 2011; 26: 324-328. Epub 2010 Jul 9
27. Zacharia BE, Ducruet AF, Hickman ZL, Grobelny BT, Fernandez L, Schmidt JM, Narula R, Ko LN, Cohen ME, Mayer SA, Connolly ES Jr: Renal dysfunction as an independent predictor of outcome after aneurysmal subarachnoid hemorrhage: a single-center cohort study. Stroke, 2009; 40: 2375-2381
28. Tsagalis G, Akrivos T, Alevizaki M, Manios E, Theodorakis M, Laggouranis A, Vemmos KN: Long-term prognosis of acute kidney injury after first acute stroke. Clin J Am Soc Nephrol, 2009; 4: 616-622
29. + carrier hcat-2b. Nitric Oxide, 1997; 1: 65-73
30. Bode-Boger SM, Scalera F, Kielstein JT, Martens-Lobenhoffer J, Breithardt G, Fobker M, Reinecke H: Symmetrical dimethylarginine: A new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol, 2006; 17: 1128-1134
31. Schepers E, Glorieux G, Dhondt A, Leybaert L, Vanholder R: Role of symmetric dimethylarginine in vascular damage by increasing ros via store-operated calcium influx in monocytes. Nephrol Dial Transplant, 2009; 24: 1429-1435
32. Jin R, Yang G, Li G: Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells. J Leukoc Biol, 2010; 87: 779-789
33. Cardounel AJ, Xia Y, Zweier JL: Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase: Differences in the effects of monomethyl-and dimethylarginines in the presence and absence of tetrahydrobiopterin. J Biol Chem, 2005; 280: 7540-7549
34. Won SJ, Kim DY, Gwag BJ: Cellular and molecular pathways of ischemic neuronal death. J Biochem Mol Biol, 2002; 35: 67-86